Craft

Immucor

Revenue

$380 M

FY, 2016

Immucor Summary

Company Summary

Overview
Immucor is a provider of transfusion and transplantation diagnostic products. It offers serology-based reagents, instruments, and molecular products, automated extended phenotype assays, a portfolio of products to identify deficiencies in clotting factors and detect antibodies, as well as solid organ and bone marrow transplant assisting products.
Type
Subsidiary
Status
Active
Founded
1982
HQ
Norcross, GA, US | view all locations
Website
https://www.immucor.com/
Cybersecurity rating
Sectors

Key People

  • William Cork

    William Cork, Chief Technology Officer

  • Kendall Lioon

    Kendall Lioon, Vice President, General Counsel

  • Gary Lawson

    Gary Lawson, Vice President, Global Quality Assurance and Regulatory Affairs

LocationsView all

1 location detected

  • Norcross, GA HQ

    United States

    3130 Gateway Dr

Immucor Financials

Summary Financials

Revenue (Q3, 2017)
$94.0M
Gross profit (Q3, 2017)
$58.6M
Net income (Q3, 2017)
($7.8M)
Cash (Q3, 2017)
$10.0M
EBIT (Q3, 2017)
$8.1M

Footer menu